Four cases of Trousseau syndrome associated with breast cancer that exhibited central nervous system manifestations

Abstract

Cancer-associated thrombosis is known as Trousseau syndrome (TS). Here, we report 4 cases of TS associated with advanced breast cancer that caused central nervous system (CNS) vascular events. All 4 patients experienced sudden onset of CNS symptoms. Imaging revealed multiple brain infarctions or intracranial hemorrhage and all 4 patients had leptomeningeal or brain metastasis. Laboratory findings showed hypercoagulability at diagnosis of TS. Of the 4 patients, 2 patients were treated with unfractionated heparin, while 2 patients could not undergo anticoagulant therapy. In all patients, once the TS occurred, the CNS symptoms progressed rapidly and the prognosis was very poor, 3 patients dying within about a month of diagnosis of TS. Therefore, the predictive factors of TS are important and standards and guidelines for administration of anticoagulants are needed.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2

References

  1. 1.

    Trousseau A. (1865) Phlegmasia alba dolens. Clinique Medicale de 1’Hotel-Dieu De Paris, vol 3, pp 654–712

  2. 2.

    Varki A (2007) Trousseau’s syndrome: multiple definitions and multiple mechanisms. Blood 15(110):1723–1729

    Article  Google Scholar 

  3. 3.

    Brose KM, Lee AY (2008) Cancer-associated thrombosis: prevention and treatment. Curr Oncol 15:58–67

    Article  Google Scholar 

  4. 4.

    Pineo GF, Brain MC, Gallus AS et al (1974) Tumors, mucus production, and hypercoagulability. Ann NY Acad Sci 230:262–270

    CAS  Article  Google Scholar 

  5. 5.

    Khorana AA, Francis CW, Culakova E et al (2007) Thromboembolism is a leading cause of death in cancer receiving outpatient chemotherapy. J Thromb Haemost 5:632–634

    CAS  Article  Google Scholar 

  6. 6.

    Tachihara M, Nikaido T, Wang X et al (2012) Four cases of Trousseau's syndrome associated with lung adenocarcinoma. Intern Med 51:1099–1102

    Article  Google Scholar 

  7. 7.

    Ikushima S, Ono R, Fukuda K et al (2016) Trousseau’s syndrome: cancer-associated thrombosis. Jpn J Clin Oncol 46:204–208

    Article  Google Scholar 

  8. 8.

    Wahrenbrock M, Borsig L, Le D et al (2003) Selectin–mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest 112:853–862

    CAS  Article  Google Scholar 

  9. 9.

    Kakkar AK, Levine MN, Kadziola Z et al (2004) Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). J Clin Oncol 22:1944–1948

    CAS  Article  Google Scholar 

  10. 10.

    Ishikawa M, Nakayama K, Ishibashi T et al (2016) Case series of cerebral infarction with Trousseau’s syndrome associated with malignant gynecological tumors. Mol Clin Oncol 5:138–142

    CAS  Article  Google Scholar 

  11. 11.

    Lyman GH, Bohlke K, Falanga A (2015) Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Oncol Pract 11:e442–e444

    Article  Google Scholar 

  12. 12.

    Farge D, Debourdeau P, Beckers M et al (2013) International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Thromb Haemost 11:56–70

    CAS  Article  Google Scholar 

Download references

Acknowledgements

We thank Tomas D Mayers, Medical English Communications Center, University of Tsukuba, for excellent English proofreading.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Hiroko Bando.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from the patients.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Verify currency and authenticity via CrossMark

Cite this article

Okazaki, M., Bando, H., Ichioka, E. et al. Four cases of Trousseau syndrome associated with breast cancer that exhibited central nervous system manifestations. Int Canc Conf J 9, 146–150 (2020). https://doi.org/10.1007/s13691-020-00411-9

Download citation

Keywords

  • Breast cancer
  • Venous thromboembolism
  • Trousseau syndrome